215 related articles for article (PubMed ID: 12763090)
1. Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia.
Julian MD; Martin AB; Cuellar B; Rodriguez De Fonseca F; Navarro M; Moratalla R; Garcia-Segura LM
Neuroscience; 2003; 119(1):309-18. PubMed ID: 12763090
[TBL] [Abstract][Full Text] [Related]
2. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia.
Mátyás F; Yanovsky Y; Mackie K; Kelsch W; Misgeld U; Freund TF
Neuroscience; 2006; 137(1):337-61. PubMed ID: 16289348
[TBL] [Abstract][Full Text] [Related]
3. Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease.
Lastres-Becker I; Berrendero F; Lucas JJ; Martín-Aparicio E; Yamamoto A; Ramos JA; Fernández-Ruiz JJ
Brain Res; 2002 Mar; 929(2):236-42. PubMed ID: 11864629
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats.
Chaves-Kirsten GP; Mazucanti CH; Real CC; Souza BM; Britto LR; Torrão AS
PLoS One; 2013; 8(10):e76874. PubMed ID: 24116178
[TBL] [Abstract][Full Text] [Related]
5. Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen.
Romero J; Berrendero F; Pérez-Rosado A; Manzanares J; Rojo A; Fernández-Ruiz JJ; de Yebenes JG; Ramos JA
Life Sci; 2000; 66(6):485-94. PubMed ID: 10794065
[TBL] [Abstract][Full Text] [Related]
6. Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice.
Steiner H; Bonner TI; Zimmer AM; Kitai ST; Zimmer A
Proc Natl Acad Sci U S A; 1999 May; 96(10):5786-90. PubMed ID: 10318962
[TBL] [Abstract][Full Text] [Related]
7. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease.
González S; Scorticati C; García-Arencibia M; de Miguel R; Ramos JA; Fernández-Ruiz J
Brain Res; 2006 Feb; 1073-1074():209-19. PubMed ID: 16412990
[TBL] [Abstract][Full Text] [Related]
8. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
[TBL] [Abstract][Full Text] [Related]
9. Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets.
Lastres-Becker I; Cebeira M; de Ceballos ML; Zeng BY; Jenner P; Ramos JA; Fernández-Ruiz JJ
Eur J Neurosci; 2001 Dec; 14(11):1827-32. PubMed ID: 11860478
[TBL] [Abstract][Full Text] [Related]
10. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.
Herkenham M; Lynn AB; de Costa BR; Richfield EK
Brain Res; 1991 May; 547(2):267-74. PubMed ID: 1909204
[TBL] [Abstract][Full Text] [Related]
11. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
12. Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.
Romero J; Berrendero F; Garcia-Gil L; de la Cruz P; Ramos JA; Fernández-Ruiz JJ
Neuroscience; 1998 Jun; 84(4):1075-83. PubMed ID: 9578396
[TBL] [Abstract][Full Text] [Related]
13. [Role of endogenous cannabinoids in cerebral reward mechanisms].
Wenger T; Fürst S
Neuropsychopharmacol Hung; 2004 Mar; 6(1):26-9. PubMed ID: 15125311
[TBL] [Abstract][Full Text] [Related]
14. The cannabinoid-1 receptor is abundantly expressed in striatal striosomes and striosome-dendron bouquets of the substantia nigra.
Davis MI; Crittenden JR; Feng AY; Kupferschmidt DA; Naydenov A; Stella N; Graybiel AM; Lovinger DM
PLoS One; 2018; 13(2):e0191436. PubMed ID: 29466446
[TBL] [Abstract][Full Text] [Related]
15. Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease.
Lastres-Becker I; Fezza F; Cebeira M; Bisogno T; Ramos JA; Milone A; Fernández-Ruiz J; Di Marzo V
Neuroreport; 2001 Jul; 12(10):2125-9. PubMed ID: 11447320
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic innervation of the basal ganglia in the squirrel monkey as revealed by tyrosine hydroxylase immunohistochemistry.
Lavoie B; Smith Y; Parent A
J Comp Neurol; 1989 Nov; 289(1):36-52. PubMed ID: 2572613
[TBL] [Abstract][Full Text] [Related]
17. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
[TBL] [Abstract][Full Text] [Related]
18. Pre- and postsynaptic localization of GABA(B) receptors in the basal ganglia in monkeys.
Charara A; Heilman TC; Levey AI; Smith Y
Neuroscience; 2000; 95(1):127-40. PubMed ID: 10619469
[TBL] [Abstract][Full Text] [Related]
19. c-fos antisense reduces expression of Krox 24 in rat caudate and neocortex.
Dragunow M; Tse C; Glass M; Lawlor P
Cell Mol Neurobiol; 1994 Oct; 14(5):395-405. PubMed ID: 7621502
[TBL] [Abstract][Full Text] [Related]
20. Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study.
Hohmann AG; Herkenham M
Neuroscience; 1999 Mar; 90(3):923-31. PubMed ID: 10218792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
